Original Article

Echocardiographic evaluation of heart failure in dogs with myxomatous mitral valve disease: a retrospective study

Donghyun Han1,†, Dong-Guk Lee1,†, Dong-In Jung2,*http://orcid.org/0000-0002-5116-6006
Author Information & Copyright
1Center of the Heart Clinic, Jukjeon Animal Medical Center, Daegu 42633, Korea
2Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Korea

These authors contribute equally to this work.

*Corresponding author: Dong-In Jung Institute of Animal Medicine, College of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Korea Tel: +82-55-772-2361, Fax: +82-55-772-2308, E-mail: jungdi@gnu.ac.kr

© Research Institute of Veterinary Medicine, Chungbuk National University. All rights reserved.

Received: Nov 20, 2018; Accepted: Dec 10, 2018

Abstract

Echocardiography is one of the most useful diagnostic techniques for differentiating heart disease as well as mitral valve lesion. Forty client-owned small breed dogs (weight, 2.3−13.2 kg) aged between 8−17 years with myxomatous mitral valve degeneration (MMVD) were included in the present study. The diagnosis of MMVD in dogs was made based on the clinical signs, chest radiography data, and echocardiographic findings. Echocardiographic examinations were conducted in accordance with recommended standards for dogs. M-mode, Doppler, and 2D echocardiography were performed in left and right lateral recumbency. 2D echocardiography was used to measure LA and Ao diameter from 2D short axis at the level of the aortic valve. In the comparison of conventional echocardiography indices in dogs with different stages of heart failure with MMVD, significant differences were observed in E/A ratio (p=0.005), EDV (p<0.001), EDVI (p<0.001), E-peak velocity (p= 0.001), ESV (p=0.028), ESVI (p=0.004), LA (p<0.001), LA/Ao Ratio (p<0.001), LVIDd (p<0.001), LVIDd/Ao Ratio (p<0.001), LVIDs (p=0.036), LVIDs/Ao Ratio (p=0.002), and MR Velocity (p=0.026). In addition, distinct correlations were found in EDV (r=0.712), LA/Ao ration (r=0.830), LVIDd (r=0.724), and LVIDd/Ao ratio (r=0.759).

This study found that known conventional echocardiographic indices, including EDV, LA/Ao ratio, LVIDd dimension, and LVIDd/Ao ratio correlated with the severity of MMVD in point of significant differences and distinct correlations.

Keywords: myxomatous mitral valve disease; heart failure; echocardiography; dog; retrospective

Introduction

Myxomatous mitral valve disease (MMVD) is the most common cardiac disease in dogs and is characterized by chronic myxomatous mitral valvular degeneration resulting in mitral regurgitation (MR) [1−4]. Transthoracic echocardiography is the diagnostic method of choice to identify mitral valve lesions and determine the severity of MR. The technique is also useful to assess the degree of cardiac remodeling and myocardial dysfunction as well as changes in left ventricular filling pressures and pulmonary arterial pressure [1, 5−9].

Echocardiography is one of the most useful diagnostic techniques to differentiate between the types of heart disease. In addition, mitral valve lesions can also be identified using two-dimensional and M-mode echocardiography [1, 10, 11]. One study found that the severity of mitral valve prolapse (MVP) significantly correlated with that of MR [12]. Color-flow doppler imaging (CDI) is useful to detect and evaluate the degree of MR in dogs with MMVD. Studies have also reported correlation between the degree of left atrium (LA) dilation, assessed by the LA to aorta (LA/Ao) ratio, and the severity of heart failure [13-15]. Left ventricle (LV) volume overload may commonly occur with increasing severity of MR, due to volume retention, remodeling, and elevations in LA and pulmonary venous pressures [16]. Therefore, an increase in the end-diastolic volume (EDV) may correlate with the severity of MR in dogs with MMVD [17]. The common indices of left ventricular systolic myocardial function such as ejection fraction (EF) and fractional shortening (FS) are generally elevated in dogs with MMVD due to increased preload, reduced afterload, and hyperdynamic ventricular contraction [18]. Systolic myocardial dysfunction may also be observed in dogs with advanced stages of MMVD [5, 7, 19].

Spectral doppler methods, including pulsed wave Doppler (PWD) and continuous-wave Doppler (CWD) are useful to determine regurgitant jet, trans-mitral flow in dogs with MMVD. Diastolic function and left ventricular filling pressures can be assessed using the PWD method [20], while CWD is useful to assess the severity of MR and thus provides information on LA pressure, preload, and systemic arterial pressure [5].

The present study evaluated the conventional echocardiographic indices to assess the severity and progression of MMVD in dogs.

Materials & Methods

Study population

Forty small breed dogs (weight, 2.3−13.2 kg) aged between 8−17 years with MMVD were included. All dogs with MMVD had been presented for a cardiology consultation due to previous identification of a heart murmur, presence of clinical signs indicating cardiovascular disorder, including cough and exercise intolerance, or both. The consent of the owner for inclusion of each dog was obtained before enrolment in the study. All dogs underwent physical examination, echocardiography, complete blood count, and chemistry panel investigations. Dogs with other clinically relevant systemic diseases, such as renal failure and hypertension were excluded. Diagnosis was made based on clinical signs, chest radiography data, and echocardiographic findings, according to the standard guidelines for the diagnosis of MMVD in dogs [21]. The dogs with MMVD were classified based on the criteria proposed by the American College of Veterinary Internal Medicine (ACVIM) for the functional classification of heart failure [21]. Dogs with symptomatic MMVD were prescribed medications such as enalapril, furosemide, spironolactone, pimobendan, and amlodipine depending upon the severity of the condition.

Echocardiography

Echocardiographic examinations were conducted in accordance with recommended standards for dogs. Mmode, Doppler, and 2D echocardiography (Acuson X-300, Siemens, Mountain view, CA) were performed in left and right lateral recumbency. 2D echocardiography was used to measure LA and Ao diameter from 2D short axis at the level of the aortic valve. These measurements were used to determine LA/Ao ratio and left ventricular internal dimension in diastole (LVIDd) to aorta (LVIDd/Ao) ratio. M-mode echocardiography was used to measure left ventricular internal dimension in systole (LVIDs) and LVIDd from 2D short axis at the level of the papillary muscle. EDV was calculated using the following formula [7 × (LVIDd) 3 / (2.4 + LVIDd)] and end-systolic volume (ESV) was calculated as [7 × (LVIDs) 3 / (2.4 + LVIDs)]. End diastolic volume index (EDVI) was calculated as follows: EDV was divided by the body surface area (BSA) that is calculated by body weight (BW, kg). End systolic volume index (ESVI) was calculated by dividing the ESV by BSA. BSA of each dog was calculated using the formula: (10.1 × BW0.67) / 100. %FS was calculated using the formula [(LVIDd−LVIDs) / LVIDd] × 100 and %EF was calculated as [(EDV−ESV) / EDV] × 100. Continuous and pulse wave Doppler echocardiography was used to measure MR velocity, E-peak velocity and A-peak (A, late ventricular diastolic filling wave) velocity from apical four chamber view. These measurements were used to determine the E-peak velocity to A-peak velocity (E/A) ratio.

Statistical analyses

Statistical analyses were performed using commercially available statistical software (SPSS 12.0). Continuous variables are presented as mean ± standard deviation (SD). Differences in echocardiographic indices among groups were evaluated using one way ANOVA. Pearson’s correlation of bivariate correlation analysis was used to test the strength of association between heart failure stage as ACVIM classification and echocardiographic indices used for evaluation of the severity. In all comparisons, a probability value of p<0.05 was considered statistically significant, unless stated otherwise.

Results

Study population

Forty dogs (22 females and 18 males) were enrolled in this study. Demographic characteristics of the study population are summarized in Table 1. Dogs with remodeled asymptomatic heart disease due to MMVD (B2 stage, 12.0 ± 1.5) were slightly older than any other groups of dogs (Table 1). In addition, dogs with remodeled asymptomatic heart disease (B2 stage, 4.3 ± 2.3) and symptomatic heart failure due to MMVD (C stage, 4.3 ± 2.8) were slightly heavier than dogs in any other groups (Table 1).

jbtr-19-4-79-t1
Table 1. Demographic characteristics of the study population
Download Original Figure
Breed distribution

The breeds of dogs included in this study are as follows (Table 1): Cocker Spaniel (2/40; 5.0%), Cross breed (2/40; 5.0%), Dachshund (2/40; 5.0%), Maltese (14/40; 35.0%), Miniature Pinscher (1/40; 2.5%), Miniature Schnauzer (1/40; 2.5%), Pekingese (1/40; 2.5%), Pomeranian (1/40; 2.5%), Shih Tzu (10/40; 25.0%), and Yorkshire Terrier (6/40; 15.0%). Maltese and Shih Tzu were the most common breeds of dogs included in this study. Maltese (2/5; 40.0%), Pomeranian (1/5; 20.0%), Shih Tzu (1/5; 20.0%), and Yorkshire Terrier (1/5; 20.0%) belonged to the B1 stage as per ACVIM, while Cocker Spaniel (1/9; 11.1%), Maltese (3/9; 33.3%), Miniature Schnauzer (1/9; 11.1%), Pekingese (1/9; 11.1%), Shih Tzu (2/9; 22.2%), and Yorkshire Terrier (1/9; 11.1%) were in the B2 stage. Cocker Spaniel (1/22; 4.5%), Cross breed (3/22; 13.6%), Dachshund (2/22; 9.1%), Maltese (7/22; 31.8%), Miniature Pinscher (1/22; 4.5%), Shih Tzu (5/22; 22.7%), and Yorkshire Terrier (3/22; 13.6%) were in ACVIM C stage. In addition, Maltese (2/4; 550.0%) and Shih Tzu (2/4; 50.0%) belonged to ACVIM D stage. Maltese and Shih Tzu breed were overrepresented in all groups.

Evaluation of trans-mitral profiles and other conventional echocardiographic indices

The conventional echocardiographic indices in the included study population are summarized in Table 2. In the comparison of conventional echocardiography indices in dogs with different stages of heart failure with MMVD, significant differences were observed in E/A ratio (p=0.005), EDV (p<0.001), EDVI (p<0.001), E-peak velocity (p=0.001), ESV (p=0.028), ESVI (p=0.004), LA (p<0.001), LA/Ao ratio (p<0.001), LVIDd (p<0.001), LVIDd/Ao ratio (p<0.001), LVIDs (p=0.036), LVIDs/Ao ratio (p=0.002), and MR velocity (p=0.026). In addition, distinct correlations were found in EDV (r=0.712), LA/ Ao ration (r=0.830), LVIDd (r=0.724), and LVIDd/Ao ratio (r=0.759).

jbtr-19-4-79-t2
Table 2. Comparison of conventional echocardiographic variables in dogs with different stage of heart failure with MMVD
Download Original Figure

Discussion

Several prognostic indicators have been identified using echocardiography and biomarkers in dogs with MMVD [22]. The ESVI, LA/Ao ratio, E-peak velocity, EDVI, and bilateral mitral valve leaflet engagement are established echocardiographic indices in dogs with MMVD [23]. In this study, the above-mentioned echocardiographic indices correlated with the severity of heart failure (i.e. progression of MMVD).

The LA/Ao ratio is generally indicated to the degree of LA dilation and shows satisfactory correlation with the stage of heart failure stage [10]. One study reported significant correlation of the LA/Ao ratio exceeding 1.7 with survival time [23]. Therefore, the LA/Ao ratio increases significantly with worsening of MMVD. In the present study, the LA/Ao ratio correlated with the severity of heart failure (Fig. 1A).

jbtr-19-4-79-g1
Fig. 1. Echocardiographic evaluation in dogs with different stages of heart failure (MMVD). A. Comparison of LA/Ao ratio, B. Comparison of EDV, C. Comparison of LVIDd/Ao ratio, D. Comparison of LVIDd. *p<.05; **p<.01; ***p<.001. MMVD, myxomatous mitral valve disease; EDV, end diastolic volume; LVIDd, left ventricular internal dimension in diastole.
Download Original Figure

LVIDd and LVIDs indicate the degree of LV dilation by LV volume/pressure overload and have found to correlate with the severity of MMVD in dogs [17, 24]. In the present study, LVIDd index was significantly different and distinct correlation in dogs with different stages of heart failure with MMVD (Fig. 1D). As the reference range for LVIDd and LVIDs in dogs differed depending upon the breed, the LVIDd/Ao and LVIDs/Ao ratio may be a more favorable indicator for evaluation of the degree of LV dilation [20]. As expected, the LVIDd/Ao and LVIDs/Ao ratio were significantly different in dogs with different stages of heart failure and correlated with the severity of MMVD in the included study population (Fig. 1C). The EDVI is the index that is obtained by dividing the EDV by the BSA of the animal. Increase in EDV is affected by left ventricular volume overload, which has been reported to indirectly depict the severity of MMVD [5, 25]. In the present study, EDV was significantly different with the severity of heart failure with MMVD (Fig. 1B). However, the volume of the LA and LV do not completely reflect the pressure of the chambers because the chamber pressure may be affected by the compliance of the chamber wall and preload [26−30].

The EF and FS are the most common echocardiographic indices for representing LV systolic function. Several factors including preload, afterload, and left ventricular contractility can affect the measures of EF and FS [31]. Although lower FS and EF suggested poor preload, increased afterload, or decreased left ventricular contractility [31−33], the measures tended to increase with an escalation in the ACVIM class, because significant MR could lead to an increase in preload and decrease in afterload [7]. As reported in other studies, the present study also observed an increase in FS and EF in dogs with advanced stage of heart failure.

The trans-mitral flow velocities, including E and A, indicate myocardial diastolic function and left ventricular filling pressure [20]. Although several factors including age, heart rate, preload, myocardial relaxation, chamber compliance, and volume can influence trans-mitral flow velocities [28, 29, 34−37], some studies observed elevation in the values with progression of MMVD in dogs [38−40]. Generally, the E-peak velocity exceeding 1.5 m/s strongly indicates severe LA volume overload causing marked elevation of LA pressure and LV filling pressure [5]. In the present study, the E-peak velocity was significantly different in dogs with different stages of heart failure and correlated with the severity of MMVD.

The A-peak velocity is commonly lower than E-peak [41]. Higher A-peak velocity when compared to E-peak (so-called E/A reversal) suggests impaired myocardial relaxation. In addition, increased A-peak velocity indicates LA pressure overload. In the present study, the A-peak velocity and E/A ratio were not significantly different in dogs with different stage of heart failure, suggesting that myocardial diastolic function might not be affected by the progression of MMVD. However, several studies have reported diastolic dysfunction in dogs with advanced stage of heart failure [39, 42, 43].

MR velocity indicates the pressure gradient from LV to LA at systole and commonly ranges between 5−6 m/s [1, 5]. MR velocity can be influenced by several innate factors (e.g. loading condition, systolic blood pressure and LV contractibilty); therefore, the measure does not generally correlate with the severity of MMVD in dogs [24]. However, recent studies reported that MR velocity could be significantly dropped when dogs faced with mortality [20, 24]. However, unlike other studies, the MR velocity in the present study was significantly different in dogs with different stage of heart failure and was the highest in dogs in the ACVIM D stage, suggesting a strong correlation with the severity of MMVD.

The present study is associated with several limitations. First, the sample size was small to obtain results with definitive statistical significance. Second, several echocardiographic parameters may be influenced by hemodynamic changes by amounts of MR and systolic blood pressure [5, 18, 20]. Those two parameters can be affected by the excitement during the echocardiography, although echocardiography was performed in calm conditions with minimal restraint. Third, there was no wide-ranging deviation in the body weight of the included dogs. Echocardiographic indices such as EDV and LVIDd may vary significantly depending on the body weight of the animal. EDV and LVIDd showed favorable significance and correlation with the severity of heart disease in the present study due to minor deviation in the weights of the included animals. Finally, medications can affect cardiac contractility and loading conditions and thus may influence the echocardiographic indices. Many dogs in advanced stages of heart failure were under cardiac medication, suggesting that the echocardiographic indices could have been different, if medications were withheld. Therefore, further studies are warranted to evaluate the influence of cardiac medications on the echocardiographic indices.

In conclusion, the present study observed that the known conventional echocardiographic indices, including EDV, LA/Ao ratio, LVIDd dimension, and LVIDd/ Ao ratio correlated with the severity of MMVD in point of significant differences and distinct correlations.

References

1..

Boon JA. Acquired heart disease: mitral insufficiency. In: Boon JA (ed.). Manual of veterinary echocardiography. Baltimore: Williams & Wilkins; 1998. p. 261-286.

2..

Gouni V, Serres FJ, Pouchelon JL, Tissier R, Lefebvre HP, Nicolle AP, Sampedrano CC, Chetboul V. Quantification of mitral valve regurgitation in dogs with degenerative mitral valve disease by use of the proximal isovelocity surface area method. J Am Vet Med Assoc 2007;231:399-406.

3..

Kittleson MD, Brown WA. Regurgitant fraction measured by using the proximal isovelocity surface area method in dogs with chronic myxomatous mitral valve disease. J Vet Intern Med 2003;17:84-88.

4..

Muzzi RA, de Araujo RB, Muzzi LA, Pena JL, Silva EF. Regurgitant jet area by Doppler color flow mapping: quantitative assessment of mitral regurgitation severity in dogs. J Vet Cardiol 2003;5:33-38.

5..

Bonagura JD, Schober KE. Can ventricular function be assessed by echocardiography in chronic canine mitral valve disease? J Small Anim Pract 2009;50:12-24.

6..

Chiavegato D, Borgarelli M, D’Agnolo G, Santilli RA. Pulmonary hypertension in dogs with mitral regurgitation attributable to myxomatous valve disease. Vet Radiol Ultrasound 2009;50:253-258.

7..

Serres F, Chetboul V, Tissier R, Poujol L, Gouni V, Carlos Sampedrano C, Pouchelon JL. Comparison of 3 ultrasound methods for quantifying left ventricular systolic function: correlation with disease severity and prognostic value in dogs with mitral valve disease. J Vet Intern Med 2008;22:566-577.

8..

Serres FJ, Chetboul V, Tissier R, Carlos Sampedrano C, Gouni V, Nicolle AP, Pouchelon JL. Doppler echocardiography- derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001–2005). J Am Vet Med Assoc 2006; 229:1772-1778.

9..

Stepien RL. Pulmonary arterial hypertension secondary to chronic left-sided cardiac dysfunction in dogs. J Small Anim Pract 2009;50:34-43.

10..

Bonagura JD, Herring DS. Echocardiography. Acquired heart disease. Vet Clin North Am Small Anim Pract 1985;15:1209-1224.

11..

Kvart C, Häggström J. Acquired valvular heart disease. In: Ettinger S, Feldman E (eds.). Textbook of veterinary internal medicine. 6th ed. Philadelphia: WB Saunders; 2005. p. 1022-1039.

12..

Terzo E, Di Marcello M, McAllister H, Glazier B, Lo Coco D, Locatelli C, Palermo V, Brambilla PG. Echocardiographic assessment of 537 dogs with mitral valve prolapse and leaflet involvement. Vet Radiol Ultrasound 2009;50:416-422.

13..

Buchanan JW, Kelly AM. Endocardial splitting of the left atrium in the dog with hemorrhage and hemopericardium. Vet Radiol Ultrasound 1964;5:28-38.

14..

Peddle GD, Buchanan JW. Acquired atrial septal defects secondary to rupture of the atrial septum in dogs with degenerative mitral valve disease. J Vet Cardiol 2010;12:129-134.

15..

Sadanaga KK, MacDonald MJ, Buchanan JW. Echocardiography and surgery in a dog with left atrial rupture and hemopericardium. J Vet Intern Med 1990;4:216-221.

16..

Katayama K, Tajimi T, Guth BD, Matsuzaki M, Lee JD, Seitelberger R, Peterson KL. Early diastolic filling dynamics during experimental mitral regurgitation in the conscious dog. Circulation 1988;78:390-400.

17..

O’Gara P, Sugeng L, Lang R, Sarano M, Hung J, Raman S, Fischer G, Carabello B, Adams D, Vannan M. The role of imaging in chronic degenerative mitral regurgitation. JACC Cardiovasc Imaging 2008;1:221-237.

18..

Kienle R, Thomas W. Echocardiography. In: Nyland TG, Mattoon JS (eds.). Small animal diagnostic ultrasound. 2nd ed. Philadelphia: WB Saunders; 2002. p. 354-423.

19..

Kittleson MD, Eyster GE, Knowlen GG, Bari Olivier N, Anderson LK. Myocardial function in small dogs with chronic mitral regurgitation and severe congestive heart failure. J Am Vet Med Assoc 1984;184:455-459.

20..

Chetboul V, Tissier R. Echocardiographic assessment of canine degenerative mitral valve disease. J Vet Cardiol 2012;14:127-148.

21..

Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, Haggstrom J, Hamlin R, Keene B, Luis-Fuentes V, Stepien R. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med 2009;23:1142-1150.

22..

Olsen LH, Häggström J, Petersen HD. Acquired valvular heart disease. In: Ettinger SJ, Feldman E (eds.). Textbook of veterinary internal medicine. 7th ed. Philadelphia: W.B. Saunders; 2010. p. 1299-1319.

23..

Borgarelli M, Savarino P, Crosara S, Santilli RA, Chiavegato D, Poggi M, Bellino C, La Rosa G, Zanatta R, Haggstrom J, Tarducci A. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. J Vet Intern Med 2008;22:120-128.

24..

Hezzell MJ, Boswood A, Moonarmart W, Elliott J. Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease. J Vet Cardiol 2012;14:269-279.

25..

Uretsky S, Supariwala A, Nidadovolu P, Khokhar SS, Comeau C, Shubayev O, Campanile F, Wolff SD. Quantification of left ventricular remodeling in response to isolated aortic or mitral regurgitation. J Cardiovasc Magn Reson 2010;12:32.

26..

Gaasch WH, Levine HJ, Quinones MA, Alexander JK. Left ventricular compliance: mechanisms and clinical implications. Am J Cardiol 1976;38:645-653.

27..

Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000;102:1788-1794.

28..

Schober KE, Bonagura JD, Scansen BA, Stern JA, Ponzio NM. Estimation of left ventricular filling pressure by use of Doppler echocardiography in healthy anesthetized dogs subjected to acute volume loading. Am J Vet Res 2008; 69:1034-1049.

29..

Schober KE, Stern JA, DaCunha DN, Pedraza-Toscano AM, Shemanski D, Hamlin RL. Estimation of left ventricular filling pressure by Doppler echocardiography in dogs with pacing-induced heart failure. J Vet Intern Med 2008; 22:578-585.

30..

Stefanadis C, Dernellis J, Toutouzas P. A clinical appraisal of left atrial function. Eur Heart J 2001;22:22-36.

31..

Aurigemma G, Douglas P, Gaasch W. Quantitative evaluation of left ventricular structure, wall stress, and systolic function. In: Otto C (eds.). The practice of clinical echocardiography. 2nd ed. Philadelphia: WB Saunders Company; 2002. p. 65-87.

32..

Kittleson M. Left ventricular function and failure-part I. Comp Cont Ed 1994;16:287-308.

33..

Kittleson M. Left ventricular function and failure-part II. Comp Cont Ed 1994;16:1001-1017.

34..

Oh JK, Appleton CP, Hatle LK, Nishimura RA, Seward JB, Tajik AJ. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997; 10:246-270.

35..

Oyama MA, Sisson DD, Bulmer BJ, Constable PD. Echocardiographic estimation of mean left atrial pressure in a canine model of acute mitral valve insufficiency. J Vet Intern Med 2004;18:667-672.

36..

Schober KE, Hart TM, Stern JA, Li X, Samii VF, Zekas LJ, Scansen BA, Bonagura JD. Detection of congestive heart failure in dogs by Doppler echocardiography. J Vet Intern Med 2010;24:1358-1368.

37..

Schober KE, Hart TM, Stern JA, Li X, Samii VF, Zekas LJ, Scansen BA, Bonagura JD. Effects of treatment on respiratory rate, serum natriuretic peptide concentration, and Doppler echocardiographic indices of left ventricular filling pressure in dogs with congestive heart failure secondary to degenerative mitral valve disease and dilated cardiomyopathy. J Am Vet Med Assoc 2011;239:468-479.

38..

Patel AR, Mochizuki Y, Yao J, Pandian NG. Mitral regurgitation: comprehensive assessment by echocar-diography.Echocardiography 2000;17:275-283.

39..

Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ, Spinale FG. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 1998;97:1708-1715.

40..

Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ, American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;4:237-261.

41..

Boon JA. The M-mode and Doppler examination. In: Boon JA (ed.). Veterinary echocardiography. 2nd ed. West Sussex: Jone Wiley & Sons; 2011. p. 101-152.

42..

Bruch C, Stypmann J, Gradaus R, Breithardt G, Wichter T. Usefulness of tissue Doppler imaging for estimation of filling pressures in patients with primary or secondary pure mitral regurgitation. Am J Cardiol 2004;93:324-328.

43..

Nagueh SF, Sun H, Kopelen HA, Middleton KJ, Khoury DS. Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 2001;37:278-285.